The Alliance of Community Health Plans (ACHP) has submitted a comment letter about the U.S. Patent and Trademark’s Office (USPTO) initiatives to ensure the robustness and reliability of patent rights. In the letter, ACHP urges USPTO to consider several reforms to address the high cost of drugs.
New from ACHP:
- ACHP Statement on MAHA Commission
- ACHP Statement on Confirmation of Robert F. Kennedy Jr. as HHS Secretary
- ACHP Letter to CMS on CY 2026 MA and Part D Rate Notice
- ACHP Letter to CMS on Proposed CY 2026 Policy and Technical Changes
- ACHP Letter to National Association of Medicaid Directors
- ACHP Statement on 2027 Medicare Drug Negotiations